Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12FU4 | ISIN: US92346J1088 | Ticker-Symbol: ATQP
Tradegate
21.05.24
17:40 Uhr
47,200 Euro
+0,600
+1,29 %
1-Jahres-Chart
VERICEL CORPORATION Chart 1 Jahr
5-Tage-Chart
VERICEL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
46,40047,20011:52
46,40047,20011:46

Aktuelle News zur VERICEL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiVericel Corporation: Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 20241
DiMultiple Factors Pushed Vericel Corp. (VCEL) in Q11
09.05.Critical Insights From Vericel Analyst Ratings: What You Need To Know2
08.05.Vericel Corp - 10-Q, Quarterly Report2
08.05.Vericel GAAP EPS of -$0.08 beats by $0.03, revenue of $51.3M beats by $2.23M1
08.05.Vericel Corporation: Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance92Total Revenue Increased 25% to $51.3 Million Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63% Adjusted EBITDA Growth of 325% Full-Year 2024 Revenue Guidance Raised...
► Artikel lesen
07.05.Vericel Q1 2024 Earnings Preview1
03.05.Vericel Corp - 8-K, Current Report1
24.04.Vericel Corporation: Vericel to Report First-Quarter 2024 Financial Results on May 8, 20241
01.03.Earnings call: Vericel reports revenue over $197 million in Q43
29.02.Vericel Corp reports results for the quarter ended in December - Earnings Summary1
29.02.Vericel Corp - 10-K, Annual Report-
29.02.Vericel GAAP EPS of $0.26 beats by $0.09, revenue of $65M beats by $1.05M1
29.02.Vericel Corp - 8-K, Current Report-
29.02.Vericel Corporation: Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance200Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0 Million, with Adjusted EBITDA Growth of 50% Fourth...
► Artikel lesen
28.02.Vericel Q4 2023 Earnings Preview1
27.02.Vericel Corporation: Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 20241
15.02.Vericel Corporation: Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 20242
05.02.Vericel Corporation: Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 20241
25.01.Vericel upgraded at Truist on growth acceleration potential3
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1